Your Crystallisation, Solid State and Preformulation Partner
Maximise the chance of your small molecule success. Leverage CatSci’s 40+ years’ collective experience in crystallisation, solid state and preformulation.
Speak to our experts about your crystallisation, solid state and preformulation projects
Why Choose CatSci?
Crystallisation and Solid State Expertise
Dr Robert Dennehy, our Director of Material Sciences leads our material sciences team. Robert has 20+ years of Large Pharma experience in the field of crystallisation and solid state of pharmaceuticals.
His industry experience and integrated approach to particle science and preformulation development allow him to solve customers’ problems effectively with a high degree of scientific rigour.
Dr Gary Parsons, our Director of Pharmaceutical Development, leads our preformulation team. Gary has 20+ years of Large Pharma experience in formulation development of small molecules, proteins, and RNA-based therapeutics.
Gary is committed to integrating API material science into dosage form design to give customers flexibility and optionality when it comes to pharmaceutical product design.
Through our end-in-mind approach we link particle science to formulation and process understanding, maximising the chance of your small molecule success
Our integrated chemical development, material science, preformulation and analytical development teams offer a holistic approach to medicines development, breaking down the barriers between drug substance and drug product.
SmartPath is our innovative digital tool that risk assesses your API, project, and formulation data and offers actionable mitigation strategies from our crystallisation and solid state expert, Dr Robert Dennehy.
When it comes to your API project you need to know what the risks are, the threat they pose, and how to alleviate them. SmartPath eliminates the guesswork and presents you with answers.